Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.44 |
| ▸ | HTT | P42858 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | FPR2 | P25090 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3184145 | 0.98 | TBXAS1 (0.51) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| Phosphoric Acid SCHEMBL28987144 | 0.93 | FDPS (0.50) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| SCHEMBL9694649 | 0.87 | TBXAS1 (0.41) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| Imidazoleacetic Acid SCHEMBL360337 | 0.83 | — | — | |
| Imidazoleacetic Acid SCHEMBL2172193 | 0.82 | TBXAS1 (0.59) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| Imidazoleacetic Acid SCHEMBL15007471 | 0.82 | TBXAS1 (0.56) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| Imidazoleacetic Acid SCHEMBL17375738 | 0.82 | TBXAS1 (0.56) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| SCHEMBL8519473 | 0.81 | TBXAS1 (0.50) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| SCHEMBL14321816 | 0.81 | TBXAS1 (0.47) | TBXAS1GAASMN1; SMN2TAAR1HTT | |
| Imidazoleacetic Acid SCHEMBL2827600 | 0.80 | TBXAS1 (0.54) | TBXAS1GAASMN1; SMN2TAAR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113733262-A | Surface dipping wear-resistant treatment process for environment-friendly plate | 雪宝家居集团有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-100355737-C | Pyruvic acid type ionic liquid and its preparing method | UNIV EAST CHINA NORMAL (CN) | 2007-12-19 | — | — | CN | claimed |
| CN-1821228-A | Pyruvic acid type ionic liquid and its preparing method | UNIV EAST CHINA NORMAL (CN) | 2006-08-23 | — | — | CN | claimed |
| US-5995869-A | Reduction of skin sensitization in electrotransport drug delivery | ALZA CORPORATION (US) | 1999-11-30 | — | — | US | claimed |
| US-5912010-A | ADMINISTERING LOOP DIURETIC ALONE OR WITH MAST CELL DEGRANULATOR OR GLUCOCORTICOSTEROID | E.R. SQUIBB & SONS, INC. (US) | 1999-06-15 | — | — | US | claimed |
| US-5843979-A | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-12-01 | — | — | US | claimed |
| WO-1997047355-A1 | REDUCTION OF SKIN SENSITIZATION IN ELECTROTRANSPORT DRUG DELIVERY | ALZA CORPORATION (US) | 1997-12-18 | — | — | WO | claimed |
| US-5686100-A | Prophylactic and therapeutic treatment of skin sensitization and irritation | E.R. SQUIBB & SONS, INC. (US) | 1997-11-11 | — | — | US | claimed |
| EP-0612525-A1 | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-08-31 | — | — | EP | claimed |
| JP-61293393-A | — | — | None | — | — | JP | disclosed |
| US-12201595-B2 | Compositions and methods for increasing muscle mass and strength, treating skin, reducing wear and degradation from aging and exposure and improving recovery from stress such as exercise and trauma | CALWOOD NUTRITIONALS, LLC (US) | 2025-01-21 | — | — | US | disclosed |
| US-20220175708-A1 | COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND STRENGTH, TREATING SKIN, REDUCING WEAR AND DEGRADATION FROM AGING AND EXPOSURE AND IMPROVING RECOVERY FROM STRESS SUCH AS EXERCISE AND TRAUMA | CALWOOD NUTRITIONALS, LLC (US) | 2022-06-09 | — | — | US | disclosed |
| US-11285124-B2 | Compositions and methods for increasing muscle mass and strength, treating skin, reducing wear and degradation from aging and exposure and improving recovery from stress such as exercise and trauma | CALWOOD NUTRITIONALS, LLC (US) | 2022-03-29 | — | — | US | disclosed |
| CN-113733262-A | Surface dipping wear-resistant treatment process for environment-friendly plate | 雪宝家居集团有限公司 | 2021-12-03 | — | — | CN | disclosed |
| US-4859591-A | Transamination process for producing amino acids | W. R. GRACE & CO.-CONN. (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0120208-B1 | MICROBIOLOGICALLY PRODUCED L-PHENYLALANIN-DEHYDROGENASE, PROCESS FOR OBTAINING IT AND ITS USE | Degussa Aktiengesellschaft (DE) | 1989-03-22 | — | — | EP | disclosed |
| JP-S61293393-A | DNA BASE SEQUENCE AND PRODUCTION OF AMINO ACID USING SAID SEQUENCE | MITSUI TOATSU CHEM INC | 1986-12-24 | — | — | JP | disclosed |
| US-4590161-A | AEROBIC CULTIVATION OF BREUIBACTERIUM | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1986-05-20 | — | — | US | disclosed |
| EP-0120208-A2 | Microbiologically produced L-phenylalanin-dehydrogenase, process for obtaining it and its use | Degussa Aktiengesellschaft (DE) | 1984-10-03 | — | — | EP | disclosed |
| US-4100161-A | Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids | THE JOHNS HOPKINS UNIVERSITY (US) | 1978-07-11 | — | — | US | disclosed |